View the Detailed Agenda
Complete the quick form below to download the agenda (a copy will also be sent to you via email)
The Second Annual National Forum on Pre-Approval Access
Integrating treatment-use trials into the clinical development of new therapeutics for serious diseases
- The Biggest Event in Expanded Access
After last year’s success, we are targeting 300+ attendees for Round 2. Our new venue has capacity to comfortably seat the leaders from industry, medical academia, policy institutes, and non-profit organizations.
- A Special Summit Format
Get past the basics quickly and chart new ground into pivotal issues such as reimbursement, investigator engagement, secondary data assets, and integration with clinical research. Our panel format works!
- The Best Venue
Experience our premier conference at the historic National Press Club, with discounted rooms at the JW Marriott, located only one block away.
- The Most Credible Material
The Summit is produced and organized by subject matter experts, not by a conference company. We launched the Summit in 2017 to establish a definitive national forum for advancing our space. Let’s build on that success!
- The Strongest Speakers
We know the top speakers in Expanded Access, and we carefully select them from a deep pool of industry experts plus delegates from FDA, NIH, and CMS. Many good speakers don’t make our list.
- The Highest Production Quality
Breakthroughs happen when attendees and speakers are happy! So you’ll be taken care of with gourmet food, comfortable seating, deluxe audio/video, and lots of extras!
The top conference on pre-approval treatment access, by design!
Take advantage of our negotiated room rate of $269/night for a King room.
Online reservations are now open.
Highlights from the
2017 Expanded Access Summit
Join Attendees from world-class
companies and organizations
2017 groups included Pfizer, Takeda, Janssen, Bayer, Eli Lilly, Biogen, Alnylam, Vertex, Bluebird, Amicus, Ultragenyx, AmpliPhi, Wave Life Sciences, Neuralstem, Incyte, Asuragen, Astellas, Tesaro, Ovid, Spectrum, ALS Association, Parent Project Muscular Dystrophy, Kids V Cancer, BIO, FDA, NIH, Patient Advocate Foundation, the FNIH Biomakers Consortium, and more.
What People Say about the Summit
The Expanded Access Summit provided attendees a front row seat for a lively exchange of opinions by distinguished KOLs addressing the ethical and logistical challenges in providing marginalized patients with earlier access to experimental therapies.
Great speakers / topics and overall very well done.
The Expanded Access Summit provided a platform where attendees could not only get up to speed on changes regarding Expanded Access but could also have an open dialogue. And the food was superb!